MEET DR. STEPHEN CULP
Stephen C. Culp MD, FACC, FSCAI
Dr. Culp is certified by the American Board of Internal Medicine in Internal Medicine and Cardiovascular Disease. He has practiced in Sarasota since 1995. He received his undergraduate education at Yale and was awarded the “Berkeley College Master’s Prize” at graduation.
Dr. Culp received his medical degree from the University of Vermont College of Medicine. He obtained his specialty internship and residency training in Internal Medicine at Duke University, where he was selected as the Assistant Chief Medical Resident in Internal Medicine. He also received his subspecialty training in general and interventional cardiology at Duke, and then joined the full-time faculty with a position in the Private Diagnostic Clinic, with the rank of Assistant Professor of Medicine.
For the past 18 consecutive years he has been acknowledged by his peers as a Castle-Connelly Top Doctor. He maintains a strong commitment to research and training, maintaining an adjunct faculty position at Duke, and serving as principal investigator in multiple medical trials. In today’s complex medical environment, Dr. Culp’s training has prepared him to manage whatever problem the patient brings from the common to complex.
Top Doctors Designation
Dr. Stephen Culp has earned designation as a Top Doctor by Castle Connelly every year since 2004. This prestigious honor is awarded to physicians after a thorough vetting process and based on nomination by their peers locally and from around the country. Physicians do not and cannot pay for this designation. The rigorous process that Castle Connelly uses in awarding this designation can be viewed directly on the Castle-Connelly website.
EDUCATION
Yale University, New Haven, Connecticut
Master’s Prize
B.S., Biology
University of Vermont, College of Medicine, Burlington, Vermont
M.D.
POSTGRADUATE TRAINING
Internship in Internal Medicine, Duke University Medical Center, Durham, North Carolina
Residency in Internal Medicine, Assistant Chief Medical Resident,
Duke University Medical Center, Durham, North Carolina
Fellowship in Interventional Cardiology, Duke University Medical Center, Durham, North Carolina
PRACTICE AFFILIATIONS
2014, Culp Private Medicine, LLC
2010-2013, Stephen Culp Cardiology, PA
2000-2010, Heart Specialists of Sarasota, Founding Member and Managing Partner
1995-2000, Heart Center of Sarasota, Partner
1992-1995, Private Diagnostic Clinic, Duke University Medical Center
HOSPITAL AFFILIATIONS
Current: Sarasota Memorial Hospital
Chief Cardiology Section 1999-2000
Current: Doctors Hospital of Sarasota
1986-1995, Duke University Medical Center
1990-1995, Duke University Clinical Outreach Program, Columbus County Hospital, Granville Memorial Medical Center, Cabarrus Memorial Hospital
ACADEMIC FACULTY AFFILIATIONS
1995-Present, Assistant Consulting Professor of Medicine, Duke University Medical Center
1993-1995, Assistant Professor of Medicine, Duke University Medical Center
1992-1993, Associate in Medicine, Duke University Medical Center
1994, Professor (Hon.) Department of Cardiology, Beijing Hospital, Beijing, China
BOARD CERTIFICATIONS
Certified by the American Board of Internal Medicine:
- Internal Medicine
- Cardiovascular Disease
Licensures:
- State of North Carolina Medical License
- State of California Medical License
- State of Florida Medical License
Awards and Distinctions:
- 2004-Present, Castle-Connelly Top Doctors List
- 1989, Assistant Chief Medical Resident, Duke University Medical Center
- 1979, Master’s Prize, Berkley College, Yale University
Professional Societies:
- Fellow American College of Cardiology
- Fellow of the Society for Cardiovascular Angiography and Interventions
- Sarasota County Medical Society
INVITED SPEAKER ENGAGEMENTS
- 5th Annual Symposium & Live Case Course, Cardiovascular Interventions, Tampa, Florida
- 4th Annual Symposium & Live Case Course, Cardiovascular Interventions, Tampa, Florida
- Okinawa International Cardiology Course, Live Case Demonstrations, Okinawa, Japan
- 3rd Annual Symposium and Live Case Course, Cardiovascular Interventions, Tampa, Florida
- Intravascular Ultrasound Simulcourse, Stanford University & Washington Hospital Center, Washington, DC
- University of Osaka, Department of Cardiology, Osaka, Japan
- Scripps Clinical Cardiology Course, La Jolla, California
- 1st Annual Korea Interventional Cardiology
Live Case Demonstrations, Inchon, Korea - WWSB ABC7 Television Health Segment Reports, Sarasota, Florida
- Beijing and Hong Kong, China
- Okinawa, Kagoshima, Nagasaki, and Osaka, Japan
- Inchon, Korea
- Taipei, Republic of China
- Bangkok, Thailand
- Johannesburg, Pretoria, Capetown, and Durban, South Africa
- Tampa, Orlando, Boca Raton, West Palm Beach, Fort Lauderdale, Pensacola, and Jacksonville, Florida
- Memphis, Tennessee
- Little Rock, Arkansas
- La Jolla, California
- Washington, D. C.
PUBLICATIONS
Vetto JT, Culp SC, Smythe TB, Chang AE, Sindelar WF, Sugarbaker PH, Heit HA, Giordano JM, Kosloff L: Iliac arterial-enteric fistulas occurring after pelvic irradiation.” Surgery 101: 643-647
Chapman GD, Lim CS, Gammon RS, Culp SC, Desper SJ, Bauman RP, Swain JL, Stack RS: Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res 71: 27-33.
Buller CE, Culp SC, Sketch MH, Phillips HR, Virmani R, Stack RS:
Thermal/perfusion balloon coronary angioplasty: in-vivo evaluation. Am Heart J 125:226-233.
Hausmann D, Ervel R, Alibelli-Chmarin M, et al. The Safety of
Intravascular Ultrasound: A Multicenter Survey of 2207 Examinations. Circulation 91: 623-630.
Labinaz M, Culp SC, Kisslo KB, Brott BC, Phillips HR, Stack RS. lntravascular Ultrasound in the Management of Acute Coronary Artery Dissection: A case-report. Catheterization and Cardiovasular Diagnosis.
BOOK CHAPTERS
Culp SC, Brott BC: Experimental animal models of atherosclerosis. Editors: Roubin, Califf, O’Neill, Phillips, and Stack. Interventional Cardiovascular Medicine: Principles and Practice.
MN, Jr., Culp SC, Stack RS: Thermal perfusion angioplasty. Editors: Roubin, Califf, O’Neill, Phillips, and Stack. Interventional Cardiovascular Medicine: Principles and Practice.
ABSTRACTS
Chapman GD, Lim CS, Gammon RS, Culp SC, Bauman RP, Swain JL, Stack RS: An interventional approach to coronary gene transfer. Circ 84: Suppl II-69.
Buller CE, Culp SC, Davidson CJ, Tenaglia AN, Phillips HR, Stack RS: Thermal vs. conventional perfusion balloon angioplasty in an in-vivo atherosclerotic model. Circ 84: Suppi 11-301.
Culp SC, Buller CE, Virmani R, Chapman GD, Gammon RS, Sketch MH, Jr., Stack RS: Thermal/Perfusion balloon angioplasty: chronic experimental results. Clinical Res. 40:256A
Culp SC, Chapman GD, Jackman JD, Jr., Zidar JP, Sketch MH, Jr., Stack RS: Perfusion balloon angioplasty: in-vivo comparison of catheters with different rates of flow. Clinical Res 40: 257A.
Culp SC, Buller CE, Virmani R, Sketch MH, JR., Phillips HR, Stack RS: Thermal perfusion balloon angioplasty in an in-vivo atherosclerotic rabbit model. Circ 86 (Suppl 1): 1-733.
Chapman GD, Lim CS, Gammon RS, Culp SC, Bauman RP, Swain JL, Stack RS: In vivo gene transfer into the arterial wall without a transrection vehicle. J Am Coll Cardiol 19 (Suppi A): 392A.
Zidar JP, Gammon RS, Chapman GD, Culp SC, Brott BD, Clark H, Bauman RP, Waller BF, Phillips HR, Stack RS: Short and long-term vascular tissue response to the Duke Bioabsorbable Stent. J Am Coll Cardiol 21 (Suppl A) 439A.
Zidar JP, Mohammed SF, Culp SC, Brott BC, Phillips HR, stack RS: IN vitro thrombo-genicity analysis of a new bioabsorbable, balloon-expandable, endovascular stent. J Am Coll Cardiol 21 (Suppl A): 483A.
Zidar JP, Virmani R, Culp SC, Bauman RP, Wells HA, Gammon RS, Chapman GD, Jackman JD., Phillips HR, Stack RS: Quantitative histopathologic analysis of the vascular response to Heparin coating of the Cordis stent. J AM Coll Cardiol 21 (Suppl A): 336A.
Tanguay JF, Labinaz M, Culp SC, Armstrong BA, Brott BC, Zidar JP, Phillips JR, Stack RS. Comparison of acute luminal enlargement in PTCA and stent with intravascular ultrasound. Can J Cardiol 10, (Suppl C).
SCIENTIFIC & MEDICAL ADVISORY BOARDS
- 2004-2014, Boston Scientific, Maple Grove, Minnesota
- 2013, Fractional Flow Reserve and Intravascular Ultrasound Advisory Board, Boston Scientific, Maple Grove, Minnesota
- Member 2000-Present, Duke University Cooperative Cardiology Studies Group; Board of Directors 2000-2002
- 1997, International Cardiovascular Advisory Board, Siemens Medical Imaging Systems, Bamberg, Germany
- 1992-1994, Educational Board, Cardiovascular Imaging Systems
MEDIA ENGAGEMENTS
- CNN Airport News
- WWSB-TV 7
- WSRQ Talk Radio
PEER RECOGNITION
Castle Connelly Top Doctors List, 2004-Present
CLINICAL TRIALS
Bridge
Principal Investigator
SAFE PCI
Sub Investigator
MHICC CAIN3 STUDY
Principal Investigator
TIMI38: TRITON Study
Principal Investigator
ATHENA Study
Sub-Investigator
STRADIVARIUS Study
Principal Investigator
PLATO Study
Principal Investigator
RELY Study
Principal Investigator
SPIRIT IV Study
Principal Investigator
BLOOM ARENA Study
Principal Investigator
Rely
Principal Investigator
Saturn
Principal Investigator
Relyable
Principal Investigator
DalPLAQUE 2
Principal Investigator
TIMI26: JUMBO PCI Study
Block Platelets Optimally
Principal Investigator
TIMI30: PROTECT Study
Block Platelets Optimally
Sub-Investigator
ACCLAIM: CHF Study
Vasogen
Sub-Investigator
VALENTIS: PAD Study
Gene Therapy
Sub-Investigator
TAXUS: Stent Study
Saphenous Vein Graft
Principal Investigator
PRIDE: Triactiv Study
Saphenous Vein Graft
Sub-Investigator
PFIZER: IVUS Study
Coronary Heart Disease
Principal Investigator
ACTIVATE: IVUS Study
ACAT Inhibitor in CAD
Principal Investigator
CREDO: Clopidogrel for Reduction of Events
During Observation
Bristol Myers Squibb/Sanofi, Phase III
A to Z:
Efficacy and Tolerability of Early Treatment with
Simvastatin in Tirofiban-Treated ACS Pts
Merck, Phase IV
Nice-3: Pilot Study of Enoxaparin Therapy in Patients with
Unstable Angina and Non-Q-Wave MI:
Safety of Concomitant Use with GPIIb/IIIa Inhibitors
Aventis,
SAFER Study: Distal Occlusion Device in vein grafts
PercuSurge, Inc. Principal Investigator
TETAMI: Acute MI pts. not thrombolysed
Enoxaparin vs. IV unfractionated Heparin & Tirofiban vs. Placebo
Rhône-Poulenc Rorer, Phase III, Sub-Investigator
Presto:
Prevention of Restenosis by Tranilast and its outcomes
SmithKline Beecham Phase III, Principal Investigator
Symphony II: Acute Coronary Syndrome Trial
Sibrafiban vs. Aspirin (Oral Anti-Platelet-GP IIb/IIIa)
Hoffman LaRouche, Phase III, Co-Principal Investigator
Amistad II: Acute Anterolateral Myocardial Infarction
Adenosine as an Adjunct to Reperfusion Therapy,
Sub-Investigator
Valiant: High Risk Patients post MI
Long term Valsartan, Captopril, and their combination
Sub-Investigator
Rocket 2: Coronary Artery Disease
Roxifiban in combination with aspirin
Sub-Investigator
AVE STENT: ULTRA – GFXTM Acute/Threatened Closure Registry
2.5mm Stent Interventional Study
AVE, Phase II, Principal Investigator
Palmaz-Schatz Mini-Crown Stent Trial
2.25, 2.5, 3.0, & 3.25mm Stent Interventional Study
Cordis Co., Phase II, Principal Investigator
Timi 14A: Acute MI Angiography Trial
tPA/rPA + reopro + low dose heparin
Centicor, Phase II, Sub-Investigator
Symphony: Acute Coronary Syndrome Trial
Sibrafiban vs. Aspirin (Oral Anti-Platelet–GP IIb/IIIa)
Hoffman LaRouche, Phase II, Sub-Investigator
HOE 642A/2007:
HOE 642S vs. Placebo in Unstable Angina
Hoechst-Marion Roussel, Inc., Sub-Investigator
Intime: Acute MI Trial
nPA vs. tPA in Acute MI
Bristol Myers-Squibb, Sub-Investigator
Assent: Acute MI Trial
TNK-tPA in Acute MI
Genetech, Sub-Investigator
Gusto III: Acute MI Trial
rPA vs. tPA in Acute MI
Duke University, Sub-Investigator
Timi 10B: Angiography Study
TNK-tPA in Acute MI
Timi Group, Sub-Investigator
Timi 12: Acute Coronary Syndrome Trial
RO 483657 vs. Aspirin in Acute Coronary Syndrome
Timi Group, Sub-Investigator
Multi-Link: Interventional / Stent Trial
ACS Multi-Link Stent vs. J& J Stent
ACS, Sub-Investigator
Pursuit: Acute Coronary Syndrome Trial
Integrelin vs. Placebo in Unstable Angina
Duke University, Sub-Investigator
Azimilide: Atrial Fibrillation Study
Oral Azimilide vs. Placebo in Paroxysmal
Proctor & Gamble, Sub-Investigator
IV Azimilide: Atrial Fibrillation Study
IV Azimilide vs. Placebo in Paroxysmal
Proctor & Gamble, Sub-Investigator
Timi 11: Acute Coronary Syndrome Trial
Enoxaprin in Unstable Angina
Timi Group, Sub-Investigator
SCORES: Interventional / Stent Trial
Scimed Radius Stent vs. J&J Stent
SciMed, Sub-Investigator
ENTICES: S/P Stent Placement
Enoxaparin vs. Coumadin
Rhone Poulel-Rhorer, Principal Investigator
AVID: IVUS S/P Stent Placement
SCRIPPS Clinic, Principal Investigator
Timi 10A Pilot: Angiography Study
TNK vs. tPA in Acute MI
Timi Group, Sub-Investigator
